Jump to content

All Article Types 


change article type:

Epichem Gains 51% Interest in JV for Development for New Treatment in Diabetes

Download attachment:
Epichem Gains 51 Percent Interest in JV for Development for New Treatment in Diabetes.pdf


« Back to News page

News Archives

2011

This page was printed from the PharmAust website - visit us at http://www.pharmaust.com/